Cargando…
Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease
Alzheimer’s disease (AD) is an irreversible neurodegenerative disease with clinical symptoms of memory loss and cognitive impairment. Currently, no effective drug or therapeutic method is available for curing this disease. The major strategy used is to identify and block AD at its initial stage. Thu...
Autores principales: | Liu, Xingyun, Liu, Yibiao, Liu, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216588/ https://www.ncbi.nlm.nih.gov/pubmed/37232876 http://dx.doi.org/10.3390/bios13050515 |
Ejemplares similares
-
Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood
por: Liu, Yibiao, et al.
Publicado: (2022) -
Electrochemical immunosensor based on superwettable microdroplet array for detecting multiple Alzheimer’s disease biomarkers
por: Huang, Zhen, et al.
Publicado: (2022) -
Biomarker sensing platforms based on fluorescent metal nanoclusters
por: Romeo, María V., et al.
Publicado: (2021) -
Vertical Graphene-Based Printed Electrochemical Biosensor for Simultaneous Detection of Four Alzheimer’s Disease Blood Biomarkers
por: Li, Mifang, et al.
Publicado: (2023) -
Carbon Dots as an Effective Fluorescent Sensing Platform for Metal Ion Detection
por: Yoo, Donggeon, et al.
Publicado: (2019)